Takeda Pharmaceutical Co Ltd (TAK)
13.07
-0.16
(-1.21%)
USD |
NYSE |
Apr 25, 16:00
13.06
-0.01
(-0.08%)
Pre-Market: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly): 53.04B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.04B |
| September 30, 2023 | 52.22B |
| June 30, 2023 | 54.36B |
| March 31, 2023 | 57.06B |
| December 31, 2022 | 55.89B |
| September 30, 2022 | 54.51B |
| June 30, 2022 | 56.72B |
| March 31, 2022 | 61.40B |
| December 31, 2021 | 64.02B |
| September 30, 2021 | 64.64B |
| June 30, 2021 | 67.11B |
| March 31, 2021 | 70.12B |
| December 31, 2020 | 74.14B |
| September 30, 2020 | 73.32B |
| June 30, 2020 | 73.64B |
| March 31, 2020 | 74.89B |
| December 31, 2019 | 74.89B |
| September 30, 2019 | 74.20B |
| June 30, 2019 | 80.41B |
| March 31, 2019 | 77.62B |
| December 31, 2018 | 33.75B |
| September 30, 2018 | 18.50B |
| June 30, 2018 | 18.94B |
| March 31, 2018 | 19.66B |
| December 31, 2017 | 20.19B |
| Date | Value |
|---|---|
| September 30, 2017 | 20.18B |
| June 30, 2017 | 20.61B |
| March 31, 2017 | 21.45B |
| December 31, 2016 | 18.04B |
| September 30, 2016 | 19.00B |
| June 30, 2016 | 18.95B |
| March 31, 2016 | 16.13B |
| December 31, 2015 | 16.83B |
| September 30, 2015 | 16.94B |
| June 30, 2015 | 17.03B |
| March 31, 2015 | 17.41B |
| December 31, 2014 | 17.41B |
| September 30, 2014 | 18.65B |
| June 30, 2014 | 19.56B |
| March 31, 2014 | 19.71B |
| December 31, 2013 | 18.80B |
| September 30, 2013 | 19.48B |
| June 30, 2013 | 16.83B |
| March 31, 2013 | 18.21B |
| December 31, 2012 | 19.32B |
| September 30, 2012 | 19.46B |
| June 30, 2012 | 19.12B |
| March 31, 2012 | 17.48B |
| December 31, 2011 | 18.62B |
| September 30, 2011 | 18.95B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
52.22B
Minimum
Sep 2023
80.41B
Maximum
Jun 2019
65.08B
Average
64.64B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Hoya Corp | 1.607B |
| Otsuka Holdings Co Ltd | 6.559B |
| Nxera Pharma Co Ltd | 640.94M |
| PeptiDream Inc | 206.45M |
| Stemcell Holdings Inc | 6.023M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.85B |
| Shareholders Equity (Quarterly) | 47.81B |
| Debt to Equity Ratio | 0.6918 |
| Current Ratio | 1.064 |
| Net Debt Paydown Yield | -0.13% |